Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15562)	2/21/1998 1:03:00 PM
From: Joanne Fishman	Respond to of 32384

Henry, What do you think of Philip Duffy being named to the newly-created position of vice president, technical operations. Ligand, via PR Newswire, says he will "oversee Ligand's chemical formulations and analytical development activities for commercial products, as well as manufacturing, purchasing, and materials management functions." He comes to Ligand from Schein Bayer Pharmaceutical. Sounds as if lgnd is getting ready for production. Is there a timetable for this? Thanks. Joanne